Paliperidone (or INVEGA®) is mainly prescribed to treat bipolar disorder, schizophrenia, and schizoaffective disorder.
Class: Atypical (AAP)
FDA Approval: 2006
Dosage Forms: 3 mg, 6 mg, 9 mg, 12 mg
Biological Half-life: 23 hours (oral)
Side Effects: Headache, tachycardia, insomnia, hyperprolactinaemia, cough, weight gain, indigestion, movement problems
Routes of Administration: Oral, IM
Pregnancy Category: C (US)